Receptor, ErbB-2
Concept
Vocabulary Service
Overview
subject area of
-
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer Academic Article
-
HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy Academic Article
-
neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II Academic Article
-
A Novel Approach to Tumor Suppression with Microencapsulated Recombinant Cells Academic Article
-
A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer Academic Article
-
A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features Academic Article
-
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial Academic Article
-
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213. Academic Article
-
Activity of fulvestrant in HER2-overexpressing advanced breast cancer Academic Article
-
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients Academic Article
-
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial Academic Article
-
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial Academic Article
-
Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review Academic Article
-
Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes Academic Article
-
An Evaluation of the Safety of Continuing Trastuzumab Despite Overt Left Ventricular Dysfunction Academic Article
-
Anthracyclines in Early Breast Cancer Academic Article
-
Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer? Academic Article
-
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Academic Article
-
Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients Academic Article
-
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer Academic Article
-
BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays Academic Article
-
Black Cohosh Increases Metastatic Mammary Cancer in Transgenic Mice Expressing c-erbB2 Academic Article
-
Blood HER2 and Uromodulin as Causal Mediators of CKD Academic Article
-
Breast cancer risk factors and HER2 over-expression in tumors. Academic Article
-
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer Academic Article
-
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer. Conference Paper
-
Characterizing Complex Polysera Produced by Antigen-Specific Immunization through the Use of Affinity-Selected Mimotopes Academic Article
-
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial Academic Article
-
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer Academic Article
-
Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy Academic Article
-
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial Academic Article
-
Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer Academic Article
-
Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold? Academic Article
-
Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2 Academic Article
-
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression Academic Article
-
Developmental and Lactational Exposure to Dieldrin Alters Mammary Tumorigenesis in Her2/neu Transgenic Mice Academic Article
-
Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer Academic Article
-
Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies Academic Article
-
Dual-Agent Molecular Targeting of the ErbB2 Receptor: Killing One Bird With Two Stones Academic Article
-
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer Academic Article
-
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study Academic Article
-
Effectiveness of Adding Everolimus to the First-line Treatment of Advanced Breast Cancer in Premenopausal Women Who Experienced Disease Progression While Receiving Selective Estrogen Receptor Modulators Academic Article
-
Efficacy, Safety, and Immunogenicity of HLX02 Compared with Reference Trastuzumab in Patients with Recurrent or Metastatic HER2-Positive Breast Cancer: A Randomized Phase III Equivalence Trial Academic Article
-
Endocrine therapy: is the first generation of targeted drugs the last? Academic Article
-
Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor Academic Article
-
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer Academic Article
-
Epidermal growth factor receptor-dependent activation of Gab1 is involved in ErbB-2-mediated mammary tumor progression Academic Article
-
Epirubicin in Breast Cancer: Present and Future Academic Article
-
ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors Conference Paper
-
ErbB2 IS A TUMOR ASSOCIATED ANTIGEN AND A SUITABLE THERAPEUTIC TARGET IN WILMS TUMOR Academic Article
-
ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival Academic Article
-
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis Academic Article
-
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours Academic Article
-
Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer Academic Article
-
Expression of EGFR, HER-2/neu and KIT in germ cell tumours Academic Article
-
Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence Academic Article
-
Expression of c-erb B-2 oncogene product in persistent gestational trophoblastic disease Academic Article
-
Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab Academic Article
-
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients Academic Article
-
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib Academic Article
-
Genetic identification of effectors downstream of Neu (ErbB-2) autophosphorylation sites in a Drosophila model Academic Article
-
HER2 Testing in a Population-Based Study of Patients With Metastatic Breast Cancer Treated With Trastuzumab Academic Article
-
HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data Academic Article
-
HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer Academic Article
-
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer Academic Article
-
Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy Academic Article
-
Herceptest: Her2 expression and gene amplification in non-small cell lung cancer Academic Article
-
Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples Academic Article
-
INHIBITION OF WILMS TUMOR XENOGRAFT PROGRESSION BY HALOFUGINONE IS ACCOMPANIED BY ACTIVATION OF WT-1 GENE EXPRESSION Conference Paper
-
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy Academic Article
-
Identification of a Novel Luminal Molecular Subtype of Breast Cancer Academic Article
-
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy Academic Article
-
Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Academic Article
-
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators Academic Article
-
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy Academic Article
-
Impaired c-src activation and motility defects in PEA3-null fibroblasts Academic Article
-
Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12 Academic Article
-
Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2 Academic Article
-
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival Academic Article
-
Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth Academic Article
-
Invasive lobular carcinoma: to grade or not to grade Academic Article
-
Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31 Academic Article
-
Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial Academic Article
-
Locally advanced breast cancer in octogenarian women Academic Article
-
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy Academic Article
-
Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays Academic Article
-
Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Academic Article
-
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial Academic Article
-
Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming Academic Article
-
Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes Academic Article
-
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set Academic Article
-
Novel method for differentiation between Trastuzumab and host adaptive response Academic Article
-
Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer Academic Article
-
Optimizing the Delivery of Targeted Research: An Opportunity for Comparative Effectiveness Research Academic Article
-
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4 Academic Article
-
Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial Conference Paper
-
Performance of preoperative breast MRI based on breast cancer molecular subtype Academic Article
-
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Academic Article
-
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women Academic Article
-
Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells Academic Article
-
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker Academic Article
-
Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer Conference Paper
-
Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer Academic Article
-
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario Academic Article
-
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial Academic Article
-
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative Academic Article
-
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Academic Article
-
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14 Academic Article
-
Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis Academic Article
-
Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial Academic Article
-
Role of Ets transcription factors in mammary gland development and oncogenesis. Academic Article
-
Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2 Academic Article
-
Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression Academic Article
-
Salad vegetables dietary pattern protects against HER-2-positive breast cancer: A prospective Italian study Academic Article
-
Scavenging of Extracellular H2O2 by Catalase Inhibits the Proliferation of HER-2/Neu-transformed Rat-1 Fibroblasts through the Induction of a Stress Response Academic Article
-
Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression Academic Article
-
Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort Academic Article
-
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer Academic Article
-
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients Academic Article
-
Tailored targeted therapy for all: a realistic and worthwhile objective against Academic Article
-
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Academic Article
-
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32 Academic Article
-
The HER-2/neu oncogene in breast cancer: so what is new? Academic Article
-
The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase Academic Article
-
The Role of HER-2/neu Oncogene and Vimentin Filaments in the Production of the Paget's Phenotype Academic Article
-
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity Academic Article
-
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures Academic Article
-
The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis Academic Article
-
The role of circulating extracellular vesicles in breast cancer classification and molecular subtyping Academic Article
-
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications Academic Article
-
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial Academic Article
-
Trastuzumab Cardiac Side Effects: Only Time Will Tell Academic Article
-
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study Academic Article
-
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials Academic Article
-
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial Academic Article
-
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Academic Article
-
Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2 Academic Article
-
Use of ErbB-1 and ErbB-2 to Select Endocrine Therapy for Breast Cancer: Will It Play in Peoria? Academic Article